
As of FY25, RPG Life Sciences had total assets of ₹2,916 crore and borrowings of ₹538 crore, against shareholders' equity of ₹2,139 crore — a debt-to-equity ratio of 0.35.
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 2,019 |
| Borrowings | 538 |
| Other liabilities | 359 |
| Total liabilities | 2,916 |
| Fixed assets | 1,570 |
| Capital work in progress | 45 |
| Investments | 673 |
| Other assets | 673 |
| Total assets | 2,916 |
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
RPG Life Sciences reported borrowings of ₹538 crore as of FY25.
Based on the FY25 balance sheet, RPG Life Sciences' debt-to-equity ratio is 0.35 — borrowings of ₹538 crore against equity capital and reserves of ₹2,139 crore.
RPG Life Sciences' total assets were ₹2,916 crore as of FY25, including fixed assets of ₹1,570 crore and investments of ₹673 crore.
The book value per share of RPG Life Sciences is ₹951.82, based on the latest reported balance sheet.
Track RPGLIFE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.